Overview

Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, and effectiveness of LX1031 versus a placebo control in subjects with non-constipating irritable bowel syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Lexicon Pharmaceuticals